-
Founded in:
1990-03-21 -
Country:
China -
Address:
No. 777, Xidian Street, Panshi Economic Development Zone, Jilin Province -
Tax NO.:
912202011239483018 -
Registered Funds:
76.494685 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| ASIAN GINSENG |
The extract can stimulate the pancreatic tissue to secrete insulin, making the pancreatic beta cells more sensitive to glucose stress, and can also repair damaged pancreatic beta cells.
More
The extract can stimulate the pancreatic tissue to secrete insulin, making the pancreatic beta cells more sensitive to glucose stress, and can also repair damaged pancreatic beta cells. |
0 | ||
| Wild Yam P.E Diosgenine 7%-16% |
Has a significant blood sugar lowering effect
More
Has a significant blood sugar lowering effect |
0 | ||
| Calcium sulfate dihydrate |
Has a significant blood sugar lowering effect
More
Has a significant blood sugar lowering effect |
10101-41-4 | 0 | |
| ANEMARRHENAE RHIZOMA |
Has a significant blood sugar lowering effect
More
Has a significant blood sugar lowering effect |
0 | ||
| Astragali Radix |
Has a significant blood sugar lowering effect
More
Has a significant blood sugar lowering effect |
0 | ||
| Trichosanthes |
Has a significant blood sugar lowering effect
More
Has a significant blood sugar lowering effect |
0 | ||
| Poria |
Has a significant blood sugar lowering effect
More
Has a significant blood sugar lowering effect |
0 | ||
| Ophiopogonis Radix |
Has a significant blood sugar lowering effect
More
Has a significant blood sugar lowering effect |
0 | ||
| Rehmannia |
Has a significant blood sugar lowering effect
More
Has a significant blood sugar lowering effect |
0 | ||
| 1,3-Dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone |
Has a significant blood sugar lowering effect
More
Has a significant blood sugar lowering effect |
7226-23-5 | 0 | |
| STIGMA MAYDIS |
Has a significant blood sugar lowering effect
More
Has a significant blood sugar lowering effect |
0 | ||
| dogwood |
Has a significant blood sugar lowering effect
More
Has a significant blood sugar lowering effect |
0 | ||
| DGL |
Has a significant blood sugar lowering effect
More
Has a significant blood sugar lowering effect |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Zinc oxide |
|
200mg | 1314-13-2 | 21 |
| Phenol |
|
20mg | 108-95-2 | 14 |
| D-CAMPHOR |
|
54mg | 464-49-3 | 1 |
| Methyl salicylate |
|
10mg | 119-36-8 | 18 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ferrous fumarate |
Iron is a component of hemoglobin in red blood cells. When iron is deficient, the amount of hemoglobin synthesized by red blood cells decreases, causing the red blood cells to become smaller and their oxygen-carrying capacity to decrease, resulting in iron-deficiency anemia. Oral administration of this product can supplement iron and correct iron-deficiency anemia.
More
Iron is a component of hemoglobin in red blood cells. When iron is deficient, the amount of hemoglobin synthesized by red blood cells decreases, causing the red blood cells to become smaller and their oxygen-carrying capacity to decrease, resulting in iron-deficiency anemia. Oral administration of this product can supplement iron and correct iron-deficiency anemia. |
141-01-5 | 14 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Potassium chloride |
Extract from the above information
More
Extract from the above information |
7447-40-7 | 38 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Risperidone |
Risperidone is a selective monoamine antagonist with high affinity for 5HT2 receptors, D2 receptors, α1 and α2 receptors, and H1 receptors. Its therapeutic effect is believed to be the result of the combined effect of antagonism of D2 receptors and 5HT2 receptors. Antagonism of receptors other than D2 and 5HT2 may be related to other effects of risperidone.
More
Risperidone is a selective monoamine antagonist with high affinity for 5HT2 receptors, D2 receptors, α1 and α2 receptors, and H1 receptors. Its therapeutic effect is believed to be the result of the combined effect of antagonism of D2 receptors and 5HT2 receptors. Antagonism of receptors other than D2 and 5HT2 may be related to other effects of risperidone. |
106266-06-2 | 54 |